REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -66.7% | 459 | +10.9% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | -20.8% | 414 | +9.8% | 0.00% | -50.0% |
| Q2 2021 | $53,000 | -76.9% | 377 | -83.6% | 0.00% | -75.0% |
| Q1 2021 | $229,000 | +15.1% | 2,300 | +42.6% | 0.01% | -11.1% |
| Q4 2020 | $199,000 | +95.1% | 1,613 | +146.6% | 0.01% | -18.2% |
| Q2 2020 | $102,000 | +537.5% | 654 | +289.3% | 0.01% | +175.0% |
| Q2 2019 | $16,000 | +700.0% | 168 | +572.0% | 0.00% | +300.0% |
| Q1 2019 | $2,000 | -94.6% | 25 | -94.5% | 0.00% | -92.3% |
| Q3 2018 | $37,000 | +76.2% | 458 | -22.8% | 0.01% | +85.7% |
| Q2 2018 | $21,000 | – | 593 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |